These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 2462303)

  • 1. Pathophysiology and differential diagnosis of benign prostatic hypertrophy.
    Blaivas JG
    Urology; 1988 Dec; 32(6 Suppl):5-11. PubMed ID: 2462303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia.
    Oelke M; Baard J; Wijkstra H; de la Rosette JJ; Jonas U; Höfner K
    Eur Urol; 2008 Aug; 54(2):419-26. PubMed ID: 18325657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multichannel urodynamic studies in men with benign prostatic hyperplasia. Indications and interpretation.
    Blaivas JG
    Urol Clin North Am; 1990 Aug; 17(3):543-52. PubMed ID: 1695781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detrusor contraction duration as a urodynamic parameter of bladder outlet obstruction for evaluating men with lower urinary tract symptoms.
    Ameda K; Steele GS; Sullivan MP; Stember D; Yalla SV
    J Urol; 1998 Aug; 160(2):482-6. PubMed ID: 9679903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of bladder outlet obstruction and detrusor contractility on residual urine in patients with benign prostatic hyperplasia.
    Zhang P; Wu Z; Gao J
    Chin Med J (Engl); 2003 Oct; 116(10):1508-10. PubMed ID: 14570611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of maximum detrusor contraction power in relation to bladder emptying in patients with lower urinary tract symptoms and benign prostatic enlargement.
    Rosier PF; de Wildt MJ; de la Rosette JJ; Debruyne FM; Wijkstra H
    J Urol; 1995 Dec; 154(6):2137-42. PubMed ID: 7500477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of isometric detrusor pressure in patients with benign prostatic hyperplasia].
    Nishimoto K
    Hinyokika Kiyo; 1990 Jan; 36(1):19-26. PubMed ID: 1689929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents.
    Kuo HC
    Urology; 2004 May; 63(5):868-72. PubMed ID: 15134967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of the diagnostic criteria of bladder outlet obstruction in benign prostatic hyperplasia].
    Shuang W; Wang D; Zhang X; Liu C; Cao X; Wang J; Gao J; Ren Z; Lü Y
    Zhonghua Nan Ke Xue; 2004 Oct; 10(10):743-6. PubMed ID: 15562786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of functional examination techniques for the assessment of the clinical aspects of benign prostatic hyperplasia].
    Hohenfellner M; Thüroff JW
    Urologe A; 1992 May; 31(3):142-9. PubMed ID: 1377431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urodynamic characterization of nonobstructive voiding dysfunction in symptomatic elderly men.
    Ameda K; Sullivan MP; Bae RJ; Yalla SV
    J Urol; 1999 Jul; 162(1):142-6. PubMed ID: 10379758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Data from frequency-volume charts versus maximum free flow rate, residual volume, and voiding cystometric estimated urethral obstruction grade and detrusor contractility grade in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Van Venrooij GE; Eckhardt MD; Boon TA
    Neurourol Urodyn; 2002; 21(5):450-6. PubMed ID: 12232879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower urinary tract symptoms in young men: videourodynamic findings and correlation with noninvasive measures.
    Nitti VW; Lefkowitz G; Ficazzola M; Dixon CM
    J Urol; 2002 Jul; 168(1):135-8. PubMed ID: 12050507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Urinary retention in herpes zoster].
    Persson C; Melchior H
    Urologe A; 1986 Sep; 25(5):286-7. PubMed ID: 2431531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Contribution of pressure-flow relationship studies in the evaluation of benign hypertrophy of the prostate].
    Haab F
    Prog Urol; 1999 Feb; 9(1):151-5. PubMed ID: 10212970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower urinary tract symptoms in the older male.
    Hsieh K; Taylor JA; Albertsen PC
    Conn Med; 2003 Sep; 67(8):487-90. PubMed ID: 14587129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
    Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
    J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship of detrusor instability and symptoms with objective parameters used for diagnosing bladder outlet obstruction: a prospective study.
    Wadie BS; Ebrahim el-HE; Gomha MA
    J Urol; 2002 Jul; 168(1):132-4. PubMed ID: 12050506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Incidence of the form and caliber of urethral resistance. Evaluation for a normal masculine urethra and in cases of obstruction due to prostatic hypertrophy].
    Glémain P; Cordonnier JP; Bochereau G; Baron M; Le Normand L; Buzelin JM
    Prog Urol; 1993 Dec; 3(6):995-1015; discussion 1006-8. PubMed ID: 7508314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical diagnosis of bladder outlet obstruction in men with lower urinary tract symptoms: reliability of commonly measured parameters and the role of idiopathic detrusor overactivity.
    Vesely S; Knutson T; Fall M; Damber JE; Dahlstrand C
    Neurourol Urodyn; 2003; 22(4):301-5. PubMed ID: 12808704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.